Efficacy and Safety of Chemotherapy Regimens in Advanced or Metastatic Bladder and Urothelial Carcinomas: An Updated Network Meta-Analysis

Background: Gemcitabine plus cisplatin (GC) and methotrexate, vinblastine, adriamycin, and cisplatin (MVAC) have been the first-line treatments for advanced or metastatic urothelial carcinoma (AMUC). However, their effects are unsatisfactory, and more drugs and regimens still need to be explored. Ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Hong-Chen, Huang, Yan, Mu, Zhong-Yi, Lv, Hang, Xie, Qing-Peng, Wang, Kai, Hu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974923/
https://www.ncbi.nlm.nih.gov/pubmed/32009946
http://dx.doi.org/10.3389/fphar.2019.01507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974923/
https://www.ncbi.nlm.nih.gov/pubmed/32009946
http://dx.doi.org/10.3389/fphar.2019.01507

Ejemplares similares